576 related articles for article (PubMed ID: 34113015)
1. Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.
Milman O; Yelin I; Aharony N; Katz R; Herzel E; Ben-Tov A; Kuint J; Gazit S; Chodick G; Patalon T; Kishony R
Nat Med; 2021 Aug; 27(8):1367-1369. PubMed ID: 34113015
[TBL] [Abstract][Full Text] [Related]
2. Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study.
Glampson B; Brittain J; Kaura A; Mulla A; Mercuri L; Brett SJ; Aylin P; Sandall T; Goodman I; Redhead J; Saravanakumar K; Mayer EK
JMIR Public Health Surveill; 2021 Sep; 7(9):e30010. PubMed ID: 34265740
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
4. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
Watson LM
N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
[TBL] [Abstract][Full Text] [Related]
5. Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
Yassi A; Grant JM; Lockhart K; Barker S; Sprague S; Okpani AI; Wong T; Daly P; Henderson W; Lubin S; Kim Sing C
PLoS One; 2021; 16(7):e0254920. PubMed ID: 34270608
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
7. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
9. The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers' unvaccinated household members.
Salo J; Hägg M; Kortelainen M; Leino T; Saxell T; Siikanen M; Sääksvuori L
Nat Commun; 2022 Mar; 13(1):1162. PubMed ID: 35246536
[TBL] [Abstract][Full Text] [Related]
10. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
[TBL] [Abstract][Full Text] [Related]
11. Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota.
Wienkes H; Vilen K; Lorentz A; Gerlach D; Wang X; Saupe A; Danila R; Lynfield R; Smith K; Medus C
JAMA Netw Open; 2022 Feb; 5(2):e220536. PubMed ID: 35212747
[TBL] [Abstract][Full Text] [Related]
12. Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response.
Ostadgavahi AT; Booth R; Sisson G; McMullen N; Warhuus M; Robertson P; Miller M; Allen WC; El Sherif M; Brownlie R; Falzarano D; Richardson CD
J Infect Dev Ctries; 2021 May; 15(5):653-656. PubMed ID: 34106888
[TBL] [Abstract][Full Text] [Related]
13. Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine.
Mizrahi B; Lotan R; Kalkstein N; Peretz A; Perez G; Ben-Tov A; Chodick G; Gazit S; Patalon T
Nat Commun; 2021 Nov; 12(1):6379. PubMed ID: 34737312
[TBL] [Abstract][Full Text] [Related]
14. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.
Levine-Tiefenbrun M; Yelin I; Katz R; Herzel E; Golan Z; Schreiber L; Wolf T; Nadler V; Ben-Tov A; Kuint J; Gazit S; Patalon T; Chodick G; Kishony R
Nat Med; 2021 May; 27(5):790-792. PubMed ID: 33782619
[TBL] [Abstract][Full Text] [Related]
15. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.
Landsberg HE; Turcinovic J; Sullivan M; Connor JH; Hamer DH; Platt JT
Int J Infect Dis; 2022 Jan; 114():62-64. PubMed ID: 34757200
[TBL] [Abstract][Full Text] [Related]
17. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
[TBL] [Abstract][Full Text] [Related]
18. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
Jeong H; Choi YM; Seo H; Kim BJ
Front Immunol; 2021; 12():637654. PubMed ID: 33732258
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.
Nigro O; Sironi G; Bergamaschi L; Gattuso G; Puma N; Livellara V; Chiaravalli S; Ferrari A; Massimino M
Pediatr Blood Cancer; 2021 Oct; 68(10):e29240. PubMed ID: 34264546
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
Baj A; Novazzi F; Genoni A; Ferrante FD; Taborelli S; Pini B; Partenope M; Valli M; Gasperina DD; Capuano R; Prestia M; Spezia PG; Azzi L; Focosi D; Maggi F
Emerg Microbes Infect; 2021 Dec; 10(1):1254-1256. PubMed ID: 34110974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
